Royalty Repurchase Agreement Sample Contracts

EX-10.3 4 d257386dex103.htm AMENDED AND RESTATED ROYALTY REPURCHASE AGREEMENT AMENDED AND RESTATED ROYALTY REPURCHASE AGREEMENT

Royalty Repurchase Agreement • May 5th, 2020 • New York

• Contract Type
  Royalty Repurchase Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

This Amended and Restated Royalty Repurchase Agreement (this “Agreement”), dated November 14, 2011, is made by and between Deerfield Private Design Fund II, L.P., a Delaware limited partnership (“Design Fund II”), Deerfield Special Situations Fund, L.P., a Delaware limited partnership (“DSS”), Horizon Santé TTNP SARL, a Luxembourg limited company (“Horizon” and together with Design Fund II and DSS, “Deerfield”) and Titan Pharmaceuticals, Inc., a Delaware corporation (“Titan”).

ROYALTY REPURCHASE AGREEMENT

Royalty Repurchase Agreement • March 18th, 2011 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Royalty Repurchase Agreement
• Filed
  March 18th, 2011
• Company
  Titan Pharmaceuticals Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Royalty Repurchase Agreement (this “Agreement”), dated March 15, 2011, is made by and between Deerfield Private Design Fund II, L.P., a Delaware limited partnership (“Design Fund II”), Deerfield Special Situations Fund, L.P., a Delaware limited partnership (“DSS” and together with Design Fund II, “Deerfield”) and Titan Pharmaceuticals, Inc., a Delaware corporation (“Titan”).